Patent Assignment
Reel/Frame 053237/0314
Assignment of Assignor's Interest
Recorded: 2020-07-17
Pages: 38
Assignee
BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
8200 VESZPREM, SZABADSAGPUSZTA, HUNGARY
Covered Property
(1)
Use of a Hydroximic Acid Halide Derivative in the Treatment of Neurodegenerative Diseases
Application:
14/594,817 →
Publication:
US 2015/0126551
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest
Jul 17, 2020
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 053241/0975 →
Assignment of Assignor's Interest
Jul 17, 2020
From: URBANICS, RUDOLF
To: CYTRX CORPORATION
Reel/Frame 053242/0011 →
Change of Name
Jul 17, 2020
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 053242/0608 →
Assignment of Assignor's Interest
Jul 17, 2020
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 053237/0259 →
Assignment of Assignor's Interest
Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Assignment of Assignor's Interest
Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →
Release of Security Interest
Apr 4, 2024
From: KREOS CAPITAL VI (UK) LIMITED
To: ZEVRA DENMARK A/S (F/K/A KEMPHARM DENMARK A/S, SUCCESSOR IN INTEREST TO ORPHAZYME A/S)
Reel/Frame 067007/0706 →